IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOSITIS (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial tests new cell therapy for devastating autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing the safety of an experimental cell therapy called FT819 for four serious autoimmune diseases: lupus, vasculitis, myositis, and scleroderma. Researchers will give FT819 to 244 participants aged 12-70 who have moderate to severe disease that hasn't…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
Stem cell shots tested to tame rare muscle disease
Disease control Recruiting nowThis study is testing whether stem cells from umbilical cord lining can help adults with dermatomyositis or polymyositis, two rare autoimmune diseases that cause muscle weakness and skin rashes. Over 25 months, 40 participants will receive three infusions of either the stem cell …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOSITIS (IIM)
Phase: PHASE2, PHASE3 • Sponsor: Restem, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC